Entrada Therapeutics Reports First Quarter 2025 Financial Results

Go back to Entrada Therapeutics Reports First Quarter 2025 Financial Results
(NASDAQ: TRDA) Delayed: 7.67 +0.63 (8.95%)
Previous Close $7.04    52 Week High
Open $7.03    52 Week Low
Day High $7.68    P/E N/A 
Day Low $6.93    EPS
Volume 263,620